A tech company and a biotech firm have launched job cuts that will eliminate well over 100 positions in San Jose.

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and ...

Valink Therapeutics (“Valink”), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain ...

Looking for the stock market outlook for the first half of 2026? See what you should consider heading into the new year to ...

The JV was formed through Corteva Catalyst, Corteva’s investment and collaboration platform. Since its launch in March of ...

This article looks at some of the latest developments in biotech letters, exploring how new tools are helping us solve big ...

The visit, which preceded the announcement of QAI, underscored growing alignment between global frontier technology companies ...

Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies ...

With a new generation of fast and affordable gene sequencers, researchers are better equipped than ever to tackle Earth’s ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...